Cargando…

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Kato, Tomoya, Nakamori, Mikihito, Matsumura, Shuichi, Nakamura, Masaki, Ojima, Toshiyasu, Fukuhara, Hiroshi, Ino, Yasushi, Todo, Tomoki, Yamaue, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477072/ https://www.ncbi.nlm.nih.gov/pubmed/34630707 http://dx.doi.org/10.3892/ol.2021.13061

Ejemplares similares

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021)

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
por: Matsumura, Shuichi, et al.
Publicado: (2021)

Oncolytic virus therapy: A new era of cancer treatment at dawn
por: Fukuhara, Hiroshi, et al.
Publicado: (2016)

Robotic radical lymphadenectomy without touching the pancreas during gastrectomy for gastric cancer
por: Ojima, Toshiyasu, et al.
Publicado: (2019)

Endoscopic treatment of esophageal fistulas after esophagectomy with injection of an alpha-cyanoacrylate monomer: a phase II study
por: Ojima, Toshiyasu, et al.
Publicado: (2018)

Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial
por: Ojima, Toshiyasu, et al.
Publicado: (2018)

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results
por: Ojima, Toshiyasu, et al.
Publicado: (2019)

Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
por: Takeuchi, Akihiro, et al.
Publicado: (2019)

Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
por: Hayata, Keiji, et al.
Publicado: (2013)

Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells
por: Kitadani, Junya, et al.
Publicado: (2018)

Triangulating stapling vs functional end-to-end stapling for cervical esophagogastric anastomosis after esophagectomy for thoracic esophageal cancer: study protocol for a randomized controlled trial
por: Tsuji, Toshiaki, et al.
Publicado: (2019)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
por: Tazawa, Hiroshi, et al.
Publicado: (2020)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial
por: Ojima, Toshiyasu, et al.
Publicado: (2020)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Syncytia Formation in Oncolytic Virotherapy
por: Burton, Chase, et al.
Publicado: (2019)

Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)

A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
por: Todo, Tomoki, et al.
Publicado: (2022)

Oncolytic Virotherapy of Canine and Feline Cancer
por: Gentschev, Ivaylo, et al.
Publicado: (2014)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

The Practical Consideration of Poliovirus as an Oncolytic Virotherapy
por: Denniston, Elizabeth, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
por: Fujiwara, Toshiyoshi
Publicado: (2019)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017)

Oncolytic Virotherapy for Breast Cancer Treatment
por: O’Bryan, Samia M., et al.
Publicado: (2018)

Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

Oncolytic Virotherapy: The Cancer Cell Side
por: Ehrlich, Marcelo, et al.
Publicado: (2021)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

The Multifaceted Role of Macrophages in Oncolytic Virotherapy
por: Hofman, Laura, et al.
Publicado: (2021)

Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021)

The use of oncolytic virotherapy in the neoadjuvant setting
por: Thomas, Raquela J, et al.
Publicado: (2022)

Third‐generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice
por: Nakatake, Richi, et al.
Publicado: (2018)

Triple‐mutated oncolytic herpes virus for treating both fast‐ and slow‐growing tumors
por: Fukuhara, Hiroshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7purd2ingf2t3ffsa6lihs7p8v